1. Home
  2. BCYC vs TK Comparison

BCYC vs TK Comparison

Compare BCYC & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • TK
  • Stock Information
  • Founded
  • BCYC 2009
  • TK 1973
  • Country
  • BCYC United Kingdom
  • TK Bermuda
  • Employees
  • BCYC N/A
  • TK N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • TK Marine Transportation
  • Sector
  • BCYC Health Care
  • TK Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • TK Nasdaq
  • Market Cap
  • BCYC 581.7M
  • TK 591.5M
  • IPO Year
  • BCYC 2019
  • TK 1995
  • Fundamental
  • Price
  • BCYC $8.34
  • TK $7.89
  • Analyst Decision
  • BCYC Buy
  • TK
  • Analyst Count
  • BCYC 10
  • TK 0
  • Target Price
  • BCYC $25.00
  • TK N/A
  • AVG Volume (30 Days)
  • BCYC 401.9K
  • TK 896.1K
  • Earning Date
  • BCYC 05-01-2025
  • TK 05-07-2025
  • Dividend Yield
  • BCYC N/A
  • TK N/A
  • EPS Growth
  • BCYC N/A
  • TK N/A
  • EPS
  • BCYC N/A
  • TK 1.42
  • Revenue
  • BCYC $25,722,000.00
  • TK $1,220,374,000.00
  • Revenue This Year
  • BCYC N/A
  • TK N/A
  • Revenue Next Year
  • BCYC $0.27
  • TK N/A
  • P/E Ratio
  • BCYC N/A
  • TK $5.35
  • Revenue Growth
  • BCYC N/A
  • TK N/A
  • 52 Week Low
  • BCYC $6.10
  • TK $5.65
  • 52 Week High
  • BCYC $28.67
  • TK $9.95
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 49.88
  • TK 68.10
  • Support Level
  • BCYC $7.95
  • TK $7.59
  • Resistance Level
  • BCYC $9.55
  • TK $7.98
  • Average True Range (ATR)
  • BCYC 0.72
  • TK 0.23
  • MACD
  • BCYC 0.05
  • TK 0.10
  • Stochastic Oscillator
  • BCYC 43.98
  • TK 94.08

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

Share on Social Networks: